Takeda Pharmaceutical Co Stock Analysis

Takeda Pink Sheet Analysis Notes

About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.58. The entity last dividend was issued on the 30th of March 2023. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47347 people.The quote for Takeda Pharmaceutical Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Takeda Pharmaceutical Co contact Christophe Weber at 81 3 3278 2111 or learn more at https://www.takeda.com.

Takeda Pharmaceutical Investment Alerts

Takeda Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 50.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Takeda Pharmaceutical's market, we take the total number of its shares issued and multiply it by Takeda Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Takeda Profitablity

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Technical Drivers

As of the 28th of December, Takeda Pharmaceutical has the Risk Adjusted Performance of (0.02), coefficient of variation of (2,588), and Variance of 8.16. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takeda Pharmaceutical, as well as the relationship between them. Please validate Takeda Pharmaceutical information ratio and potential upside to decide if Takeda Pharmaceutical is priced more or less accurately, providing market reflects its prevalent price of 25.12 per share. Given that Takeda Pharmaceutical has information ratio of (0.05), we advise you to double-check Takeda Pharmaceutical Co's current market performance to make sure the company can sustain itself at a future point.

Takeda Pharmaceutical Price Movement Analysis

Takeda Pharmaceutical Outstanding Bonds

Takeda Pharmaceutical Predictive Daily Indicators

Takeda Pharmaceutical Forecast Models

Takeda Pharmaceutical's time-series forecasting models are one of many Takeda Pharmaceutical's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takeda Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Takeda Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Takeda shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Takeda Pharmaceutical. By using and applying Takeda Pink Sheet analysis, traders can create a robust methodology for identifying Takeda entry and exit points for their positions.

When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.